Scientists develop new tissue regeneration technology

Researchers at the Wexner Medical Center of Ohio State University have developed a breakthrough technology to create any type of cell to treat the body.

The transmission of Tissue or TNT Nanotransfection can create any type of cell to treat and can be used to repair damaged tissue or restore function to aging tissue.

Scientists develop new tissue regeneration technology Picture 1

The study, published in Nature Nanotechnology, has been applied to mice and pigs.

Specifically, researchers have been able to regenerate skin cells to become blood vessels in severely injured legs, unable to circulate blood. The blood vessels after transplanting will work within a week and the legs will go away quickly, in about two weeks.

Scientists develop new tissue regeneration technology Picture 2

"By using our new nanochip technology, injured or injured organs can be replaced. We have shown that the skin is a fertile land where we can develop the The type of cell of any organ is being affected or affected, " said Dr. Chandan Sen, director of the Center for Regenerative Therapy and Cell Therapy in a press release.

"With this technology, we can convert skin cells into elements of any organ with only one intervention. This process takes less than a second and does not need to be inserted into the muscle. Non-invasive The chip will be removed almost immediately, not in the body, then the cell regeneration process will begin, not only that, this technology ensures the security cells in immune control, therefore, suppressing the immune response is unnecessary ".

TNT is a nanotechnology-based chip designed to distribute cells into the body and design a specific biological mechanism for cell transformation. Renewable materials will be transported and activated with small charges that have been stored on the device.

In addition, this method does not require too much support, interference in the experimental environment, not too invasive and can be done at the time of wound care.

Clinical trials are scheduled to begin next year to test techniques on the human body.